Synbiotic approach restores intestinal homeostasis and prolongs survival in leukaemic mice with cachexia

ISME Journal

Volumn 10, Issue 6, 2016, Pages 1456-1470

  Bindels, Laure B ^a   Neyrinck, Audrey M ^a   Claus, Sandrine P ^b   Le Roy, Caroline I ^b   Grangette, Corinne ^c   Pot, Bruno ^c   Martinez, Inés ^d   Walter, Jens ^d   Cani, Patrice D ^a   Delzenne, Nathalie M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF READING   (United Kingdom)

^c UNIV LILLE   (France)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM; BIOTECHNOLOGY; CANCER; CELLS AND CELL COMPONENTS; DIGESTIVE SYSTEM; DISEASE TREATMENT; HOMEOSTASIS; IMMUNITY; METABOLISM; MICROBIAL COMMUNITY; MUSCLE; PROTEIN; RODENT; SURVIVAL;

ENTEROBACTERIACEAE; LACTOBACILLUS; LACTOBACILLUS REUTERI 100-23; MUS;

FRUCTAN; INULIN; SYNBIOTIC AGENT;

ACUTE DISEASE; ANIMAL; BACTEROIDETES; BAGG ALBINO MOUSE; CACHEXIA; CELL PROLIFERATION; COLONIC NEOPLASMS; DISEASE MODEL; DRUG EFFECTS; ENTEROBACTERIACEAE; FEMALE; GROWTH, DEVELOPMENT AND AGING; HOMEOSTASIS; INFLAMMATION; INTESTINE; INTESTINE FLORA; LACTOBACILLUS; LEUKEMIA; METABOLOMICS; MICROBIOLOGY; MOUSE; PHYSIOLOGY;

ACUTE DISEASE; ANIMALS; BACTEROIDETES; CACHEXIA; CELL PROLIFERATION; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; ENTEROBACTERIACEAE; FEMALE; FRUCTANS; GASTROINTESTINAL MICROBIOME; HOMEOSTASIS; INFLAMMATION; INTESTINES; INULIN; LACTOBACILLUS; LEUKEMIA; METABOLOMICS; MICE; MICE, INBRED BALB C; SYNBIOTICS;

EID: 84948440369     PISSN: 17517362     EISSN: 17517370     Source Type: Journal    
DOI: 10.1038/ismej.2015.209     Document Type: Article

References (57)

1. Argiles JM, Busquets S, Stemmler B, Lopez-Soriano FJ. (2014). Cancer cachexia: understanding the molecular basis. Nat Rev Cancer 14: 754-762
2. Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, et al. (2013). Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504: 451-455
3. Arthur JC, Perez-Chanona E, Muhlbauer M, Tomkovich S, Uronis JM, Fan TJ, et al. (2012). Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338: 120-123
4. Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H, et al. (2013). Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500: 232-236
5. Baracos VE, Pichard C, Attaix D. (2012). Survival: the relevant primary outcome for nutrition therapy in cancer patients. Curr Opin Clin Nutr Metab Care 15: 211-212
6. Bevins CL, Salzman NH. (2011). Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat Rev Microbiol 9: 356-368
7. Bindels LB, Beck R, Schakman O, Martin JC, De Backer FC, Sohet FM, et al. (2012). Restoring Specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model. PLoS One 7: e37971
8. Bindels LB, Delzenne NM, Cani PD, Walter J. (2015). Towards a more comprehensive concept for prebiotics. Nat Rev Gastroenterol Hepatol 12: 303-310
9. Bindels LB, Delzenne NM. (2013). Muscle wasting: The gut microbiota as a new therapeutic target? Int J Biochem Cell Biol 45: 2186-2190
10. Bindels LB, Porporato P, Dewulf EM, Verrax J, Neyrinck AM, Martin JC, et al. (2012). Gut microbiota-derived propionate reduces cancer cell proliferation in the liver. Br J Cancer 107: 1337-1344
11. Brestoff JR, Artis D. (2013). Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol 14: 676-684
12. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, et al. (2009). Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58: 1091-1103
13. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. (2010). QIIME allows analysis of high-Throughput community sequencing data. Nat Methods 7: 335-336
14. Claesson MJ, Jeffery IB, Conde S, Power SE, OConnor EM, Cusack S, et al. (2012). Gut microbiota composition correlates with diet and health in the elderly. Nature 488: 178-184
15. Cole JR, Wang Q, Fish JA, Chai B, McGarrell DM, Sun Y, et al. (2014). Ribosomal Database Project: data and tools for high throughput rRNA analysis. Nucleic Acids Res 42: D633-D642
16. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, et al. (2007). The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450: 566-569
17. Crawford PA, Crowley JR, Sambandam N, Muegge BD, Costello EK, Hamady M, et al. (2009). Regulation of myocardial ketone body metabolism by the gut microbiota during nutrient deprivation. Proc Natl Acad Sci USA 106: 11276-11281
18. Dewhirst FE, Chien CC, Paster BJ, Ericson RL, Orcutt RP, Schauer DB, et al. (1999). Phylogeny of the defined murine microbiota: altered Schaedler flora. Appl Environ Microbiol 65: 3287-3292
19. Dewulf EM, Cani PD, Claus SP, Fuentes S, Puylaert PG, Neyrinck AM, et al. (2013). Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-Type fructans in obese women. Gut 62: 1112-1121
20. Edgar RC. (2013). UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods 10: 996-998
21. Eren AM, Vineis JH, Morrison HG, Sogin ML. (2013). A filtering method to generate high quality short reads using illumina paired-end technology. PLoS One 8: e66643
22. Eriguchi Y, Takashima S, Oka H, Shimoji S, Nakamura K, Uryu H, et al. (2012). Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of alpha-defensins. Blood 120: 223-231
23. Everard A, Lazarevic V, Gaia N, Johansson M, Stahlman M, Backhed F, et al. (2014). Microbiome of prebiotic-Treated mice reveals novel targets involved in host response during obesity. ISME J 8: 2116-2130
24. Fearon K, Arends J, Baracos V. (2013). Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol 10: 90-99
25. Fearon KC, Glass DJ, Guttridge DC. (2012). Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab 16: 153-166
26. Foligne B, Nutten S, Grangette C, Dennin V, Goudercourt D, Poiret S, et al. (2007). Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J Gastroenterol 13: 236-243
27. Gavin MA, Rasmussen JP, Fontenot JD, Vasta V, Manganiello VC, Beavo JA, et al. (2007). Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445: 771-775
28. Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB. (2004). Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 17: 259-275
29. Gibson GR, Roberfroid MB. (1995). Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125: 1401-1412
30. Hooper LV, Littman DR, Macpherson AJ. (2012). Interactions between the microbiota and the immune system. Science 336: 1268-1273
31. Inaba Y, Ashida T, Ito T, Ishikawa C, Tanabe H, Maemoto A, et al. (2010). Expression of the antimicrobial peptide alpha-defensin/cryptdins in intestinal crypts decreases at the initial phase of intestinal inflammation in a model of inflammatory bowel disease, IL-10-deficient mice. Inflamm Bowel Dis 16: 1488-1495
32. Ivanov AI, Parkos CA, Nusrat A. (2010). Cytoskeletal regulation of epithelial barrier function during inflammation. Am J Pathol 177: 512-524
33. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al. (2009). Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139: 485-498
34. Kolida S, Gibson GR. (2011). Synbiotics in health and disease. Annu Rev Food Sci Technol 2: 373-393
35. Krumbeck JA, Maldonado-Gomez MX, Martinez I, Frese SA, Burkey TE, Rasineni K, et al. (2015). Introducing the concept of In Vivo Selection to identify bacterial stains with enhanced ecological performance when used in synbiotic applications. Appl Environ Microbiol 81: 2455-2465
36. Lawley TD, Walker AW. (2013). Intestinal colonization resistance. Immunology 138: 1-11
37. Lin XB, Dieleman LA, Ketabi A, Bibova I, Sawyer MB, Xue H, et al. (2012). Irinotecan (CPT-11) Chemotherapy Alters Intestinal Microbiota in Tumour Bearing Rats. PLoS One 7: e39764
38. Livingston M, Loach D, Wilson M, Tannock GW, Baird M. (2010). Gut commensal Lactobacillus reuteri 100-23 stimulates an immunoregulatory response. Immunol Cell Biol 88: 99-102
39. Louis P, Hold GL, Flint HJ. (2014). The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 12: 661-672
40. Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC, et al. (2007). Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2: 204
41. Manichanh C, Borruel N, Casellas F, Guarner F. (2012). The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol 9: 599-608
42. Mantovani A, Allavena P, Sica A, Balkwill F. (2008). Cancer-related inflammation. Nature 454: 436-444
43. Mukherjee S, Hooper LV. (2015). Antimicrobial defense of the intestine. Immunity 42: 28-39
44. Puppa MJ, White JP, Sato S, Cairns M, Baynes JW, Carson JA. (2011). Gut barrier dysfunction in the Apc (Min/+) mouse model of colon cancer cachexia. Biochim Biophys Acta 1812: 1601-1606
45. Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, Ye X, et al. (2008). Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28: 546-558
46. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, et al. (2009). Introducing mothur: opensource, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75: 7537-7541
47. Schnupf P, Gaboriau-Routhiau V, Gros M, Friedman R, Moya-Nilges M, Nigro G, et al. (2015). Growth and host interaction of mouse segmented filamentous bacteria in vitro. Nature 520: 99-103
48. Schwabe RF, Jobin C. (2013). The microbiome and cancer. Nat Rev Cancer 13: 800-812
49. Sciorati C, Touvier T, Buono R, Pessina P, Francois S, Perrotta C, et al. (2009). Necdin is expressed in cachectic skeletal muscle to protect fibers from tumor-induced wasting. J Cell Sci 122: 1119-1125
50. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. (2011). Metagenomic biomarker discovery and explanation. Genome Biol 12: R60
51. Sha S, Xu B, Kong X, Wei N, Liu J, Wu K. (2014). Preventive effects of Escherichia coli strain Nissle 1917 with different courses and different doses on intestinal inflammation in murine model of colitis. Inflamm Res 63: 873-883
52. Song Y, Liu C, Lee J, Bolanos M, Vaisanen ML, Finegold SM. (2005). Bacteroides goldsteinii sp nov isolated from clinical specimens of human intestinal origin. J Clin Microbiol 43: 4522-4527
53. Talbert EE, Metzger GA, He WA, Guttridge DC. (2014). Modeling human cancer cachexia in colon 26 tumorbearing adult mice. J Cachexia Sarcopenia Muscle 5: 321-328
54. Tilg H, Moschen AR. (2014). Microbiota and diabetes: an evolving relationship. Gut 63: 1513-1521
55. Veiga P, Gallini CA, Beal C, Michaud M, Delaney ML, DuBois A, et al. (2010). Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes. Proc Natl Acad Sci USA 107: 18132-18137
56. von Haehling S, Anker SD. (2014). Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014. J Cachexia Sarcopenia Muscle 5: 261-263
57. Winter SE, Winter MG, Xavier MN, Thiennimitr P, Poon V, Keestra AM, et al. (2013). Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 339: 708-711